Zynerba Pharmaceuticals

-$0.0783 (-7.83%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZYNE and other ETFs, options, and stocks.

About ZYNE

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on the research and development of rare and near-rare neuropsychiatric conditions.

CEO
Armando Anido
Employees
28
Headquarters
Devon, Pennsylvania
Founded
2007

ZYNE Key Statistics

Market cap
40.18M
Price-Earnings ratio
—
Dividend yield
—
Average volume
427.73K
High today
$0.9999
Low today
$0.92
Open price
$0.98
Volume
229.91K
52 Week high
$6.07
52 Week low
$0.8361

ZYNE Earnings

-$0.43
-$0.35
-$0.28
-$0.20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.23 per share
Actual
-$0.21 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure